Legis Daily

Securing Gene Synthesis Act

USA118th CongressHR-4702| House 
| Updated: 7/21/2023
Anna G. Eshoo

Anna G. Eshoo

Democratic Representative

California

Cosponsors (2)
Ted Lieu (Democratic)Julia Brownley (Democratic)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Securing Gene Synthesis Act This bill requires the Department of Health and Human Services to issue regulations to prevent the misuse of de novo gene synthesis products (i.e., manufactured gene products), including screening protocols for providers of these products. Federal agencies and entities that receive federal funds may only purchase such products from providers that comply with the screening protocols.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 18, 2023
Introduced in House
Jul 18, 2023
Referred to the House Committee on Energy and Commerce.
Jul 19, 2023

Latest Companion Bill Action

S 118-2400
Introduced in Senate
Jul 21, 2023
Referred to the Subcommittee on Health.
  • July 18, 2023
    Introduced in House


  • July 18, 2023
    Referred to the House Committee on Energy and Commerce.


  • July 19, 2023

    Latest Companion Bill Action

    S 118-2400
    Introduced in Senate


  • July 21, 2023
    Referred to the Subcommittee on Health.

Health

Related Bills

  • S 118-2400: Securing Gene Synthesis Act
Administrative law and regulatory proceduresCongressional oversightDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationGeneticsHealth technology, devices, suppliesMedical researchResearch administration and funding

Securing Gene Synthesis Act

USA118th CongressHR-4702| House 
| Updated: 7/21/2023
Securing Gene Synthesis Act This bill requires the Department of Health and Human Services to issue regulations to prevent the misuse of de novo gene synthesis products (i.e., manufactured gene products), including screening protocols for providers of these products. Federal agencies and entities that receive federal funds may only purchase such products from providers that comply with the screening protocols.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 18, 2023
Introduced in House
Jul 18, 2023
Referred to the House Committee on Energy and Commerce.
Jul 19, 2023

Latest Companion Bill Action

S 118-2400
Introduced in Senate
Jul 21, 2023
Referred to the Subcommittee on Health.
  • July 18, 2023
    Introduced in House


  • July 18, 2023
    Referred to the House Committee on Energy and Commerce.


  • July 19, 2023

    Latest Companion Bill Action

    S 118-2400
    Introduced in Senate


  • July 21, 2023
    Referred to the Subcommittee on Health.
Anna G. Eshoo

Anna G. Eshoo

Democratic Representative

California

Cosponsors (2)
Ted Lieu (Democratic)Julia Brownley (Democratic)

Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 118-2400: Securing Gene Synthesis Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresCongressional oversightDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationGeneticsHealth technology, devices, suppliesMedical researchResearch administration and funding